Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Denise B. Serra
Observed names:
D SERRA,
D. Serra,
Denise Serra
Observed institutions:
Novartis (Switzerland),
Beth Israel Deaconess Medical Center,
Harvard University,
Novartis (United States),
Novartis Institutes for BioMedical Research
ORCID:
0000-0003-0332-8127
Observed ORCID:
0000-0003-0332-8127
OpenAlex ID:
A5079483987
Effects of Dipeptidyl Peptidase-4 Inhibition on Gastrointestinal Function, Meal Appearance, and Glucose Metabolism in Type 2 Diabetes
2007
·
Adrian Vella
, Gerlies Bock
, et al.
·
Diabetes
·
201
PDF
Measurements of Islet Function and Glucose Metabolism with the Dipeptidyl Peptidase 4 Inhibitor Vildagliptin in Patients with Type 2 Diabetes
2007
·
Koichiro Azuma
, Zofia Rádiková
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
121
FTY720: Placebo‐Controlled Study of the Effect on Cardiac Rate and Rhythm in Healthy Subjects
2006
·
Robert Schmouder
, Denise Serra
, et al.
·
The Journal of Clinical Pharmacology
·
110
PDF
Pharmacokinetics and Pharmacodynamics of Vildagliptin??in??Patients?? with Type??2??Diabetes??Mellitus
2007
·
Yan-Ling He
, Denise Serra
, et al.
·
Clinical Pharmacokinetics
·
103
Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy
2011
·
Eric Lawitz
, Eliot Godofsky
, et al.
·
Antiviral Research
·
74
Dipeptidyl Peptidase-4 Inhibition by Vildagliptin and the Effect on Insulin Secretion and Action in Response to Meal Ingestion in Type 2 Diabetes
2008
·
Chiara Dalla Man
, Gerlies Bock
, et al.
·
Diabetes Care
·
62
The effect of dipeptidyl peptidase‐4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double‐blind, placebo‐controlled crossover study
2008
·
Adrian Vella
, Gerlies Bock
, et al.
·
Clinical Endocrinology
·
61
QT and QTc Interval With Standard and Supratherapeutic Doses of Darifenacin, a Muscarinic M3 Selective Receptor Antagonist for the Treatment of Overactive Bladder
2005
·
Denise B. Serra
, Melton B. Affrime
, et al.
·
The Journal of Clinical Pharmacology
·
56
Evaluation of pharmacokinetic and pharmacodynamic interaction between the dipeptidyl peptidase IV inhibitor vildagliptin, glyburide and pioglitazone in patients with Type 2 diabetes
2008
·
D. Serra
, Y.-L. He
, et al.
·
International Journal of Clinical Pharmacology and Therapeutics
·
30
Dry Eye Signs and Symptoms Persist During Systemic Neutralization of IL-1β by Canakinumab or IL-17A by Secukinumab
2015
·
Cynthia L. Grosskreutz
, Hans-Ulrich Hockey
, et al.
·
Cornea
·
25
FTY720 Pharmacokinetics in Mild to Moderate Hepatic Impairment
2005
·
J. M. Kovarik
, R. L. Schmouder
, et al.
·
The Journal of Clinical Pharmacology
·
20
Thorough QT study of the effects of vildagliptin, a dipeptidyl peptidase IV inhibitor, on cardiac repolarization and conduction in healthy volunteers
2011
·
Y.-L. He
, Y. Zhang
, et al.
·
Current Medical Research and Opinion
·
16
1045 SAFETY AND ANTIVIRAL EFFICACY OF 14 DAYS OF THE CYCOPHILIN INHIBITOR NIM811 IN COMBINATION WITH PEGYLATED INTERFERON α2a IN RELAPSED GENOTYPE 1 HCV INFECTED PATIENTS
2009
·
E. Lawitz
, R. Rouzier
, et al.
·
Journal of Hepatology
·
16
Pharmacokinetics and pharmacodynamics of the DPP-4 inhibitor, LAF237, in patients with type 2 diabetes
2005
·
Y HE
, A BALCH
, et al.
·
Clinical Pharmacology & Therapeutics
·
14
Effect of food on the oral bioavailability of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide fixed dose combination tablets in healthy subjects
2014
·
Gangadhar Sunkara
, Xuemin Jiang
, et al.
·
Clinical Pharmacology in Drug Development
·
13
Darifenacin, an M selective receptor antagonist (M SRA), does not prolong QT/QT
2005
·
A SKERJANEC
, M AFFRIME
, et al.
·
Clinical Pharmacology & Therapeutics
·
3
Single-Dose Pharmacokinetics, Safety, and Tolerability of Albinterferon Alfa-2b in Subjects with End-Stage Renal Disease on Hemodialysis Compared to Those in Matched Healthy Volunteers
2010
·
Denise B. Serra
, Haiying Sun
, et al.
·
Antimicrobial Agents and Chemotherapy
·
2
P4‐339: the Media Study: a Novel Method for Evaluating Digital Endpoints in Alzheimer's Disease
2018
·
Kristin Hannesdottir
, Oleksandr Sverdlov
, et al.
·
Alzheimer s & Dementia
·
1
Show more works
View as search
Works count:
20
Citation count:
928
H-index:
14
I10-index:
15
Year
Topic
Type
